159 related articles for article (PubMed ID: 8217795)
1. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation.
Bühler-Leclerc M; Gratwohl A; Senn HP
Br J Haematol; 1993 Jul; 84(3):443-50. PubMed ID: 8217795
[TBL] [Abstract][Full Text] [Related]
2. High incidence of conservative RAS mutations in acute myeloid leukemia.
Aurer I; Labar B; Nemet D; Ajduković R; Bogdanić V; Gale RP
Acta Haematol; 1994; 92(3):123-5. PubMed ID: 7871950
[TBL] [Abstract][Full Text] [Related]
3. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
Kurosawa M
Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
[TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
[TBL] [Abstract][Full Text] [Related]
5. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the ras gene in myelocytic leukemia by polymerase chain reaction and oligonucleotide probes.
Liu TC; Lin SF; Chen TP; Liu HW; Chang JG
J Formos Med Assoc; 1991 Sep; 90(9):825-30. PubMed ID: 1683380
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the P53 gene in acute myeloid leukaemia.
Fenaux P; Preudhomme C; Quiquandon I; Jonveaux P; Laï JL; Vanrumbeke M; Loucheux-Lefebvre MH; Bauters F; Berger R; Kerckaert JP
Br J Haematol; 1992 Feb; 80(2):178-83. PubMed ID: 1550773
[TBL] [Abstract][Full Text] [Related]
9. Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China.
Chen HC; Chen HJ; Khan MA; Rao ZZ; Wan XX; Tan B; Zhang DZ
Tumour Biol; 2011 Apr; 32(2):367-73. PubMed ID: 21080251
[TBL] [Abstract][Full Text] [Related]
10. c-fms point mutations in acute myeloid leukemia: fact or fiction?
Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
[TBL] [Abstract][Full Text] [Related]
11. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.
Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M
Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071
[TBL] [Abstract][Full Text] [Related]
12. Ras oncogene and p53 gene hotspot mutations in colorectal cancers.
Lin SY; Chen PH; Yang MJ; Chen TC; Chang CP; Chang JG
J Gastroenterol Hepatol; 1995; 10(2):119-24. PubMed ID: 7787154
[TBL] [Abstract][Full Text] [Related]
13. ras oncogene activation and occupational exposures in acute myeloid leukemia.
Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
[TBL] [Abstract][Full Text] [Related]
14. p53 mutation in the myelodysplastic syndromes.
Adamson DJ; Dawson AA; Bennett B; King DJ; Haites NE
Br J Haematol; 1995 Jan; 89(1):61-6. PubMed ID: 7833278
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of ras gene activation in myeloid leukemic cells.
Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
17. Analysis of ras gene mutations in childhood myeloid leukaemia.
Farr C; Gill R; Katz F; Gibbons B; Marshall CJ
Br J Haematol; 1991 Mar; 77(3):323-7. PubMed ID: 2012756
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in sporadic adrenocortical tumors.
Ohgaki H; Kleihues P; Heitz PU
Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
[TBL] [Abstract][Full Text] [Related]
19. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]